MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    Combination COMT inhibitor with Levodopa reduces consumption of vitamin B6

    D. Kamiyama, N. Nishikawa, S. Ueno, C. Abe, T. Hatano, N. Hattori (Tokyo, Japan)

    Objective: To investigate changes in Levodopa (LD) pharmacokinetics and changes in homocysteine, vitamin B6, and vitamin B12 in Parkinson's disease (PD) patients receiving LD formulations…
  • 2023 International Congress

    Beta LFP Power Change After Levodopa Intake in Parkinson’s Disease Patients with Chronic Sensing-Enabled DBS Systems

    M. de Neeling, M. Stam, B. van Wijk, J. Anso, R. Raike, P. Schuurman, R. de Bie, A. Buijink, M. Beudel (Amsterdam, Netherlands)

    Objective: To study the relationship between oscillatory beta activity in the subthalamic nucleus (STN) and the intake of dopaminergic medication in a group of Parkinson’s…
  • 2023 International Congress

    Fragile X Related Tremor in FMR1 Premutation Women without FXTAS

    D. Hall, T. Svymbersky, J. O'Keefe, B. Ouyang, E. Berry-Kravis (Chicago, USA)

    Objective: To determine whether there is a FMR1 premutation associated tremor in women who do not meet criteria for Fragile X-associated tremor ataxia syndrome (FXTAS)…
  • 2023 International Congress

    Response to Levodopa in Parkinson´s Disease Over Time. A 4-year Follow-up Study.

    D. Santos García, T. de Deus, C. Cores, M. Feal Painceiras, I. García-Díaz, M. íñiguez, J. Paz González, S. Jesús, M. Cosgaya, J. García Caldentey, N. Caballol, I. Legarda, J. Hernández Vara, I. Cabo, L. López Manzanares, I. González Aramburu, M. Avila, V. Gómez Mayordomo, V. Nogueira, J. Dotor, C. Borrué, B. Solano, M. álvarez Sauco, L. Vela, F. Escalante, E. Cubo, Z. Mendoza, J. Martínez Castrillo, P. Sánchez Alonso, M. Alonso Losada, N. López Ariztegui, M. Gastón, J. Kulisevsky, M. Seijo, C. Valero, R. Alonso Redondo, M. Buongiorno, C. Ordás, P. Martínez Martín, P. Mir, C. Coppadis (A Coruña, Spain)

    Objective: The aim of the present study was to analyze the response to levodopa in Parkinson´s disease (PD) patients with motor fluctuations followed up for…
  • 2023 International Congress

    Correlation between hemoglobin level and disease severity in patients with Parkinson’s disease

    O. Gavriliuc, L. Rotaru, M. Gavriliuc, A. Caldarov (Chisinau, Republic of Moldova)

    Objective: Objective of this study was to investigate the potential correlation between hemoglobin levels and Parkinson's disease (PD) severity, and to compare them with a…
  • 2023 International Congress

    Clinical spectrum, imaging characteristics and care giver burden assessment of early onset non-dominant progressive cerebellar ataxias

    R. Devaraj, P. Pal, N. M, RY. Yadav, M. Faruq, J. Saini, S. Hegde (Bangalore, India)

    Objective: To characterise the phenotypic and radiological spectrum of patients with early onset non-dominant progressive cerebellar ataxias and to assess the impact of the disease…
  • 2023 International Congress

    Musical Perception in Parkinson’s Disease, a Pilot Study

    K. Vourou (Athens, Greece)

    Objective: This pilot study aimed to investigate whether patients with PD have deficits in the perception of melody, rhythm, and musical excerpt recognition as measured…
  • 2023 International Congress

    The role of the default mode network and striatal circuits in the expression of depressive symptoms in premanifest Huntington’s disease

    T. Barta, L. Novelli, N. Georgiou-Karistianis, J. Stout, S. Loi, Y. Glikmann-Johnston, A. Razi (Clayton, Australia)

    Objective: This study aimed to investigate changes in large-scale network effective connectivity of the default mode network (DMN) and striatum in the expression of depression…
  • 2023 International Congress

    Integrative analysis of fecal metabolomics and metagenomics for Parkinson’s disease

    Y. Qian, S. Xu, X. He, Y. Lai, Y. Zhang, C. Mo, P. Ai, X. Yang, Q. Xiao (Shanghai, China)

    Objective: The objectives of the current study were to explore how the fecal metabolomics changed, and how they interacted with the alteration of microbiota in…
  • 2023 International Congress

    Apathy and impulsivity co-occur in Huntington’s disease

    L. Morris, K. Horne, L. Paermentier, C. Buchanan, M. Macaskill, D. Myall, M. Husain, R. Roxburgh, T. Anderson, C. Le Heron (Christchurch, New Zealand)

    Objective: To determine whether apathy and impulsivity co-occur in people with Huntington’s disease. Background: Apathy and impulsivity are debilitating behavioural changes which often occur in…
  • « Previous Page
  • 1
  • …
  • 141
  • 142
  • 143
  • 144
  • 145
  • …
  • 186
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley